European Companies Search Engine
EU funding (€1,763,520): European staff EXchange Programme fOr deSigning pErSonalised prevention of future healthcare Hor11 Jun 2026 EU Research and Innovation programme "Horizon"
Text
European staff EXchange Programme fOr deSigning pErSonalised prevention of future healthcare
Personalised prevention approaches stand at the forefront of precision medicine, yet their implementation into clinical practice faces numerous challenges. These hurdles include the difficulty in producing robust evidence on their clinical utility and cost-effectiveness, health systems preparedness, healthcare professionals' education, ethical, legal, and social issues, citizen literacy, and major investments in technical infrastructure and workforce training. The aim of EXPOSES is to train a new generation of health professionals in personalised prevention Europe, China and USA, thanks to 87 secondments in 4 years. The staff will attend courses, workshops, seminars, conferences, and will participate in organizing outreach activities, thus acquiring new skills. They will produce policy recommendations, scientific publications, and key reports, thus fostering public-private interactions. In the long run, the implementation of a multidisciplinary program that include institutions from EU, China and USA will contribute to an advancement of personalized prevention policies and strategies among the 3 continents. EXPOSES includes 13 beneficiaries and 3 Associated partners from 9 EU Countries, 1 Associated Country and 3 Third Countries (China and USA). 10 are academics and 6 non- academics of which 3 are SMEs. Research topics include advancing Health Technology Assessment and Health Impact Assessment evaluations for facilitating the implementation of personalised prevention approaches, policy considerations in personalised prevention, Responsible Research and Innovation (RRI), and a pilot study on genetic risk profiles for personalised breast cancer prevention in diverse populations. The work also covers evidence synthesis and research methodology to strengthen the scientific basis of personalised prevention. EXPOSES is embedded in existing cooperation structures, such as PROPHET, EU partnerships on Transforming Health and Care systems, and related Joint Actions.
Funded Companies:
| Company name | Funding amount |
| Allelica Inc. | ? |
| Asociatia Centrul Pentru Inovatie in Medicina | €105,210 |
| BDT - Health Planning Lda. | €200,400 |
| Consorcio Centro de Investigacion Biomedica en Red M.P | €150,300 |
| Departamento de Salud Gobierno Vasco | €90,180 |
| Erasmus Universitair Medisch Centrum Rotterdam | €200,400 |
| Katholieke Universiteit Leuven | €170,340 |
| Ruprecht-Karls-Universitaet Heidelberg | €55,110 |
| Sciensano | €145,290 |
| Technologiko Panepistimio Kyprou | €155,310 |
| Universita Cattolica Del Sacro Cuore | €305,610 |
| Universita Degli Studi Di Roma LA Sapienza | €185,370 |
Source: https://cordis.europa.eu/project/id/101299724
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Allelica Inc., Wilmington, United States.